Bala Niharika, Rafay Ramish H, Glover Sarah C, Alli Abdel A
Department of Medicine, Division of Nephrology, Hypertension, and Renal Transplantation, University of Florida College of Medicine, Gainesville, FL 32608, USA.
Department of Physiology and Aging, University of Florida College of Medicine, Gainesville, FL 32608, USA.
Viruses. 2024 Dec 28;17(1):25. doi: 10.3390/v17010025.
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for causing the Coronavirus disease 2019 (COVID-19) outbreak. While mutations cause the emergence of new variants, the ancestral SARS-CoV-2 strain is unique among other strains. Various clinical parameters, the activity of cathepsin proteases, and the concentration of various proteins were measured in urine samples from COVID-19-negative participants and COVID-19-positive participants. Urinary extracellular vesicles (uEVs) were isolated from urine samples from the two groups and used for proteomic analysis and subsequent pathway analyses. Activity levels of cathepsin S and L were greater in the urine of COVID-19-positive participants. The concentration of C-reactive protein, transmembrane serine protease 2, and klotho protein were significantly greater in the urine of COVID-19-positive participants. There was a greater amount of uEVs in the COVID-19 group and klotho protein was found to be enriched in uEVs from the COVID-19 group. Pathway analyses of the proteomics data showed most of the identified proteins were involved in signal transduction, stress response, protein metabolism, and transport. The identified proteins were predominantly associated with cellular membranes and with function of the cytoskeleton, enzyme regulation, and signal transduction. Taken together, our data identify novel urinary biomarkers that could be used to further investigate the long-term effects of SARS-CoV-2 infection.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)是导致2019冠状病毒病(COVID-19)疫情的病原体。虽然突变会导致新变种的出现,但原始SARS-CoV-2毒株在其他毒株中是独特的。在COVID-19阴性参与者和COVID-19阳性参与者的尿液样本中测量了各种临床参数、组织蛋白酶的活性以及各种蛋白质的浓度。从两组的尿液样本中分离出尿细胞外囊泡(uEVs),并用于蛋白质组学分析及后续的通路分析。COVID-19阳性参与者尿液中组织蛋白酶S和L的活性水平更高。COVID-19阳性参与者尿液中C反应蛋白、跨膜丝氨酸蛋白酶2和klotho蛋白的浓度显著更高。COVID-19组的uEVs数量更多,并且发现klotho蛋白在COVID-19组的uEVs中富集。蛋白质组学数据的通路分析表明,大多数鉴定出的蛋白质参与信号转导、应激反应、蛋白质代谢和转运。鉴定出的蛋白质主要与细胞膜以及细胞骨架功能、酶调节和信号转导相关。综上所述,我们的数据鉴定出了新的尿液生物标志物,可用于进一步研究SARS-CoV-2感染的长期影响。